Alvotech Valuation

ALVO Stock  USD 13.27  0.04  0.30%   
At this time, the firm appears to be undervalued. Alvotech shows a prevailing Real Value of $14.08 per share. The current price of the firm is $13.27. Our model approximates the value of Alvotech from analyzing the firm fundamentals such as Return On Asset of -0.0761, shares outstanding of 301.94 M, and Operating Margin of 0.46 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Alvotech's valuation include:
Enterprise Value
5.1 B
Enterprise Value Ebitda
(8.78)
Price Sales
12.9392
Enterprise Value Revenue
12.9048
Undervalued
Today
13.27
Please note that Alvotech's price fluctuation is not too volatile at this time. Calculation of the real value of Alvotech is based on 3 months time horizon. Increasing Alvotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alvotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alvotech Stock. However, Alvotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  13.27 Real  14.08 Target  17.4 Hype  13.21
The intrinsic value of Alvotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alvotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
14.08
Real Value
15.73
Upside
Estimating the potential upside or downside of Alvotech helps investors to forecast how Alvotech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alvotech more accurately as focusing exclusively on Alvotech's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.25-0.1-0.04
Details
Hype
Prediction
LowEstimatedHigh
11.5613.2114.86
Details
5 Analysts
Consensus
LowTarget PriceHigh
15.8317.4019.31
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Alvotech's intrinsic value based on its ongoing forecasts of Alvotech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Alvotech's closest peers.

Alvotech Cash

9.54 Million

Alvotech Valuation Trend

Knowing Alvotech's actual value is paramount for traders when making sound investment determinations. Using both Alvotech's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Alvotech Total Value Analysis

Alvotech is presently anticipated to have valuation of 5.06 B with market capitalization of 3.99 B, debt of 1.08 B, and cash on hands of 128.44 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alvotech fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
5.06 B
3.99 B
1.08 B
128.44 M

Alvotech Investor Information

About 64.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.85. Alvotech had not issued any dividends in recent years. Alvotech may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.

Alvotech Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Alvotech has an asset utilization ratio of 9.62 percent. This suggests that the Company is making $0.0962 for each dollar of assets. An increasing asset utilization means that Alvotech is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

Alvotech Ownership Allocation

Alvotech holds a total of 301.94 Million outstanding shares. Alvotech shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.01 percent of Alvotech outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Alvotech Profitability Analysis

The company reported the previous year's revenue of 91.43 M. Net Loss for the year was (551.73 M) with profit before overhead, payroll, taxes, and interest of 150.62 M.

About Alvotech Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Alvotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Alvotech based exclusively on its fundamental and basic technical indicators. By analyzing Alvotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Alvotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alvotech. We calculate exposure to Alvotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alvotech's related companies.
Last ReportedProjected for Next Year
Gross Profit-62.5 M-59.4 M
Pretax Profit Margin(8.19)(8.60)
Operating Profit Margin(4.46)(4.69)
Net Loss(6.94)(7.29)
Gross Profit Margin(0.87)(0.83)

Alvotech Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding227.3 M
Quarterly Earnings Growth Y O Y-0.696

Alvotech Current Valuation Indicators

Alvotech's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alvotech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alvotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alvotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alvotech's worth.
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.85)
Revenue Per Share
1.283
Quarterly Revenue Growth
43.997
Return On Assets
(0.08)
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.